NCT07332169Active, not recruiting
The Efficacy of Non-invasive Brain Stimulation (NIBS) on Cognitive Functions in Patients With Chronic Obstructive Pulmonary Disease (COPD)
The Efficacy of Non-invasive Brain Stimulation on Cognitive Functions in Patients With Chronic Obstructive Pulmonary Disease: Single-Blinded Randomised Controlled Trial
Source: ClinicalTrials.gov · Last updated 20 Oct 2026
Brief summary (registry, in English)
The goal of this clinical trial is to examine if non-invasive brain stimulation (NIBS) can enhance cognitive function with chronic obstructive pulmonary disease (COPD) population. The main questions it aims to answer are: * What is the possibility effect of using the NIBS on cognitive functions as well as the cardiopulmonary parameters in COPD population? * What is the relation between cognitive function parameters and cardiopulmonary parameters in COPD population who suffer from cognitive impairment (CI)? Researchers will compare NIBS to a sham-NIBS to see if NIBS works to improve cognitive function in COPD population. Participants will: Receive NIBS or a sham-NIBS 3 sessions/week for 3 weeks for 20 min each session. Visit the clinic at the beginning for baseline assessment then after the completion of the 3 weeks to reassess them. Outcome measures for cognitive parameters and pulmonary parameters will be taken pre and post NIBS intervention
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 22 (estimated)
- First submitted
- 28 Dec 2025
- Start date
- 20 Jan 2026
- Primary completion date
- 1 Jan 2028
- Lead sponsor
- Ministry of Health, Kuwait
- Diseases
- COPD
- NCT number
- NCT07332169
What you commit to
- Study type: Interventional
- Planned participants: 22
- From 20 Jan 2026 to the primary completion date, 1 Jan 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with COPD but without cognitive impairment.
- COPD patients who are contraindicated for using brain stimulation like psychiatric disorders.
Other
- Patients without COPD
- Unstable patients with several admission in the last 3 months
- COPD patients who suffered from any neurological problems
Who the study is looking for
- Adult age from 18 years old to 70 years old.
- Patients with confirmed chronic obstructive pulmonary disease (COPD) via pulmonologist
- All stages of COPD severity will be included
- Stable patients, which means they were not admitted to the hospital in the last 3 months
- Patients with COPD with confirmed cognitive impairment by Montreal Cognitive Assessment (MoCA) test.
- All MoCA stages will be included.
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Imam Abdulrahman bin Faisal University Coordinator of this site? Confirm its status | Dammam | Saudi Arabia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.